Hemophagocytic syndromes--an update

Area of Science:

• Immunology
• Hematology
• Genetics

Background:

• Hemophagocytic lymphohistiocytosis (HLH) is a critical hyperinflammatory syndrome, representing an extreme immune response rather than an independent condition.
• HLH can arise from various underlying causes, including genetic defects affecting cytotoxic cells and acquired conditions like infections, autoimmune diseases, and malignancies.

Purpose of the Study:

• To elucidate the nature of HLH as a hyperinflammatory syndrome.
• To differentiate between genetic and acquired forms of HLH.
• To outline current therapeutic strategies for HLH.

Main Methods:

• Utilized functional tests to distinguish between genetic and acquired HLH.
• Reviewed underlying conditions associated with HLH.
• Examined treatment modalities including immunomodulatory, immunosuppressive agents, and stem cell transplantation.

Main Results:

• HLH is characterized by uncontrolled hyperinflammation, stemming from genetic defects or acquired conditions.
• Functional tests are key to differentiating HLH subtypes.
• Treatment involves suppressing hypercytokinemia and eliminating affected cells, with stem cell transplantation offering a cure for genetic HLH.

Conclusions:

• HLH is a severe manifestation of immune dysregulation, not a standalone disease.
• Accurate diagnosis through functional testing is vital for guiding therapy.
• Hematopoietic stem cell transplantation, particularly with reduced-intensity conditioning, offers a curative option for genetic HLH, significantly improving survival rates.